10th Neurodegenerative Drug Development Summit 2022

congress program

Location : Boston

Country : United States

Language : ENG

Start : 2022-03-28

End : 2022-03-30

https://neurodegenerative-drug-development.com/

Specialities : Neurology

With Biogen’s Aducanumab approval dramatically overhauling the regulatory landscape for neurodegenerative disease, the beta amyloid revival is in full swing with investment pouring in across multiple neurodegenerative diseases. With this, biopharma across the globe are racing to harness the exhilarating momentum of the past year and turbocharge their neurodegenerative disease drug development in 2022 and beyond.